Stuart Chaussee & Associates’s AbbVie ABBV Stock Holding History

Stuart Chaussee & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,141	Closed	-$264K	–	2
2025 Q3	$264K	Hold	1,141	–	–	0.06%	43
2025 Q2	$212K	Hold	1,141	–	–	0.05%	42
2025 Q1	$239K	Buy	1,141 +174	+18%	+$33.8K	0.06%	36
2024 Q4	$172K	Hold	967	–	–	0.04%	37
2024 Q3	$191K	Hold	967	–	–	0.05%	32
2024 Q2	$166K	Hold	967	–	–	0.05%	32
2024 Q1	$176K	Hold	967	–	–	0.05%	32
2023 Q4	$150K	Buy	967 +154	+19%	+$22.5K	0.04%	33
2023 Q3	$121K	Hold	813	–	–	0.04%	28
2023 Q2	$110K	Hold	813	–	–	0.03%	32
2023 Q1	$130K	Hold	813	–	–	0.04%	28
2022 Q4	$131K	Hold	813	–	–	0.05%	28
2022 Q3	$109K	Hold	813	–	–	0.25%	21
2022 Q2	$125K	Hold	813	–	–	0.27%	21
2022 Q1	$132K	Sell	813 -50	-6%	-$7.26K	0.06%	28
2021 Q4	$117K	Buy	863 +5	+0.6%	+$591	0.05%	31
2021 Q3	$93K	Hold	858	–	–	0.14%	24
2021 Q2	$97K	Hold	858	–	–	0.04%	30
2021 Q1	$93K	Hold	858	–	–	0.04%	39
2020 Q4	$92K	Hold	858	–	–	0.04%	33
2020 Q3	$75K	Buy	858 +100	+13%	+$9.41K	0.03%	37
2020 Q2	$74K	Hold	758	–	–	0.04%	32
2020 Q1	$58K	Hold	758	–	–	0.05%	29
2019 Q4	$67K	Hold	758	–	–	0.04%	36
2019 Q3	$57K	Hold	758	–	–	0.03%	41
2019 Q2	$55K	Hold	758	–	–	0.03%	45
2019 Q1	$61K	Hold	758	–	–	0.04%	38
2018 Q4	$70K	Hold	758	–	–	0.05%	28
2018 Q3	$72K	Hold	758	–	–	0.05%	41
2018 Q2	$70K	Buy	+758	New	+$74K	0.05%	40

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Stuart Chaussee & Associates's ABBV Position: Q4 2025 in Review

Stuart Chaussee & Associates sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 1,141 shares — an estimated $264K sold.

Stuart Chaussee & Associates first reported a position in ABBV in Q2 2018 and held it in 30 quarters. The position peaked at $264K in Q3 2025. 4,158 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Stuart Chaussee & Associates reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
Stuart Chaussee & Associates sold 1,141 AbbVie shares in Q4 2025, an estimated $264K.
Stuart Chaussee & Associates first reported a position in AbbVie in Q2 2018 and held it in 30 quarters.
Stuart Chaussee & Associates's AbbVie position peaked at $264K in Q3 2025.
4,158 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Stuart Chaussee & Associates's 13F filing for Q4 2025.